000837084 001__ 837084
000837084 005__ 20210129231159.0
000837084 0247_ $$2doi$$a10.1016/j.seizure.2017.08.006
000837084 0247_ $$2ISSN$$a1059-1311
000837084 0247_ $$2ISSN$$a1532-2688
000837084 0247_ $$2pmid$$apmid:28843069
000837084 0247_ $$2WOS$$aWOS:000414110900020
000837084 0247_ $$2altmetric$$aaltmetric:24305944
000837084 037__ $$aFZJ-2017-06081
000837084 082__ $$a610
000837084 1001_ $$0P:(DE-HGF)0$$aMalter, M. P.$$b0$$eCorresponding author
000837084 245__ $$aNew onset status epilepticus in older patients: clinical characteristics and outcome
000837084 260__ $$aOxford [u.a.]$$bElsevier$$c2017
000837084 3367_ $$2DRIVER$$aarticle
000837084 3367_ $$2DataCite$$aOutput Types/Journal article
000837084 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1505738991_31848
000837084 3367_ $$2BibTeX$$aARTICLE
000837084 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000837084 3367_ $$00$$2EndNote$$aJournal Article
000837084 520__ $$aPurposeWe here evaluated (1) the differential characteristics of status epilepticus (SE) in older (≥60 years) compared to younger adults (18–59 years). In particular, we were interested in (2) the proportion and characteristics of new onset SE in patients with no history of epilepsy (NOSE) in older compared to younger adults, and (3) predictive parameters for clinical outcome in older subjects with NOSE.MethodsWe performed a monocentric retrospective analysis of all adult patients (≥18 years) admitted with SE to our tertiary care centre over a period of 10 years (2006–2015) to evaluate clinical characteristics and short-time outcome at discharge.ResultsOne-hundred-thirty-five patients with SE were included in the study. Mean age at onset was 64 years (range 21–90), eighty-seven of the patients (64%) were older than 60 years. In 76 patients (56%), SE occurred as NOSE, sixty-seven percent of them were aged ≥60  years. There was no age-dependent predominance for NOSE. NOSE was not a relevant outcome predictor, especially regarding age-related subgroups. Older patients with NOSE had less frequently general tonic clonic SE (GTCSE; p = 0.001) and were more often female (p = 0.01). Regarding outcome parameters and risk factors in older patients with NOSE, unfavourable outcome was associated with infections during in-hospital treatment (0.04), extended stay in ICU (p = 0.001), and generally in hospital (p < 0.001).ConclusionIn our cohort, older patients represented the predominant subgroup in patients with SE. Older patients suffered more often from non-convulsive semiology and had a less favourable short-time outcome. NOSE was not a predictive outcome parameter in older patients. Data suggest that avoiding infections should have a priority because higher infection rates were associated with unfavourable outcome.
000837084 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000837084 588__ $$aDataset connected to CrossRef
000837084 7001_ $$0P:(DE-HGF)0$$aNass, R. D.$$b1
000837084 7001_ $$0P:(DE-HGF)0$$aKaluschke, T.$$b2
000837084 7001_ $$0P:(DE-Juel1)131720$$aFink, G. R.$$b3
000837084 7001_ $$0P:(DE-HGF)0$$aBurghaus, L.$$b4
000837084 7001_ $$0P:(DE-HGF)0$$aDohmen, C.$$b5
000837084 773__ $$0PERI:(DE-600)2002585-3$$a10.1016/j.seizure.2017.08.006$$gp. S1059131117303874$$n $$p114-120$$tSeizure$$v51$$x1059-1311$$y2017
000837084 8564_ $$uhttps://juser.fz-juelich.de/record/837084/files/1-s2.0-S1059131117303874-main.pdf$$yRestricted
000837084 8564_ $$uhttps://juser.fz-juelich.de/record/837084/files/1-s2.0-S1059131117303874-main.gif?subformat=icon$$xicon$$yRestricted
000837084 8564_ $$uhttps://juser.fz-juelich.de/record/837084/files/1-s2.0-S1059131117303874-main.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000837084 8564_ $$uhttps://juser.fz-juelich.de/record/837084/files/1-s2.0-S1059131117303874-main.jpg?subformat=icon-180$$xicon-180$$yRestricted
000837084 8564_ $$uhttps://juser.fz-juelich.de/record/837084/files/1-s2.0-S1059131117303874-main.jpg?subformat=icon-640$$xicon-640$$yRestricted
000837084 8564_ $$uhttps://juser.fz-juelich.de/record/837084/files/1-s2.0-S1059131117303874-main.pdf?subformat=pdfa$$xpdfa$$yRestricted
000837084 909CO $$ooai:juser.fz-juelich.de:837084$$pVDB
000837084 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b3$$kFZJ
000837084 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000837084 9141_ $$y2017
000837084 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000837084 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSEIZURE-EUR J EPILEP : 2015
000837084 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000837084 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000837084 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000837084 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000837084 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000837084 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000837084 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000837084 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000837084 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000837084 920__ $$lyes
000837084 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000837084 980__ $$ajournal
000837084 980__ $$aVDB
000837084 980__ $$aI:(DE-Juel1)INM-3-20090406
000837084 980__ $$aUNRESTRICTED